BACKGROUND: Filamin myopathy is a neuromuscular disorder manifesting with predominantly limb-girdle muscle weakness and in many patients with diaphragm paralysis and cardiomyopathy, caused by mutations in the filamin C (FLNC) gene. Molecular diagnosis of filamin myopathy based on direct DNA sequencing of coding exons is compromised by the presence of a high homology pseudogene (pseFLNC) located approximately 53.6 kb downstream of the functional FLNC gene on chromosome 7q. METHODS: Molecular cloning, RT-PCR and real-time PCR methods were used to detect sequence differences between the FLNC and pseFLNC that are implicated in known or potential molecular diagnostic errors. Overall, 50 patients with a phenotype resembling filamin myopathy have been screened for mutations in FLNC. RESULTS: FLNC sequence inconsistencies caused by the interference from pseFLNC were identified and diagnostic errors involving, in particular, the detection of the most frequent disease-causing FLNC p.W2710X mutation resolved. Mismatches between the FLNC and pseFLNC sequences were tabulated for future use. CONCLUSIONS: We devise a strategy that allows one to discern mutations occurring in the functional FLNC from those harbored in pseFLNC, thus preventing possible complications in future research and patient genetic testing.
BACKGROUND:Filaminmyopathy is a neuromuscular disorder manifesting with predominantly limb-girdle muscle weakness and in many patients with diaphragm paralysis and cardiomyopathy, caused by mutations in the filamin C (FLNC) gene. Molecular diagnosis of filaminmyopathy based on direct DNA sequencing of coding exons is compromised by the presence of a high homology pseudogene (pseFLNC) located approximately 53.6 kb downstream of the functional FLNC gene on chromosome 7q. METHODS: Molecular cloning, RT-PCR and real-time PCR methods were used to detect sequence differences between the FLNC and pseFLNC that are implicated in known or potential molecular diagnostic errors. Overall, 50 patients with a phenotype resembling filaminmyopathy have been screened for mutations in FLNC. RESULTS:FLNC sequence inconsistencies caused by the interference from pseFLNC were identified and diagnostic errors involving, in particular, the detection of the most frequent disease-causing FLNCp.W2710X mutation resolved. Mismatches between the FLNC and pseFLNC sequences were tabulated for future use. CONCLUSIONS: We devise a strategy that allows one to discern mutations occurring in the functional FLNC from those harbored in pseFLNC, thus preventing possible complications in future research and patient genetic testing.
Authors: Dieter O Fürst; Lev G Goldfarb; Rudolf A Kley; Matthias Vorgerd; Montse Olivé; Peter F M van der Ven Journal: Acta Neuropathol Date: 2012-10-30 Impact factor: 17.088
Authors: Rudolf A Kley; Piraye Serdaroglu-Oflazer; Yvonne Leber; Zagaa Odgerel; Peter F M van der Ven; Montse Olivé; Isidro Ferrer; Adekunle Onipe; Mariya Mihaylov; Juan M Bilbao; Hee S Lee; Jörg Höhfeld; Kristina Djinović-Carugo; Kester Kong; Martin Tegenthoff; Sören A Peters; Werner Stenzel; Matthias Vorgerd; Lev G Goldfarb; Dieter O Fürst Journal: Brain Date: 2012-09 Impact factor: 13.501
Authors: Rudolf Andre Kley; Yvonne Leber; Bertold Schrank; Heidi Zhuge; Zacharias Orfanos; Julius Kostan; Adekunle Onipe; Dominik Sellung; Anne Katrin Güttsches; Britta Eggers; Frank Jacobsen; Wolfram Kress; Katrin Marcus; Kristina Djinovic-Carugo; Peter F M van der Ven; Dieter O Fürst; Matthias Vorgerd Journal: Neurol Genet Date: 2021-05-18
Authors: Kristin K McDonald; Jeffrey Stajich; Colette Blach; Allison E Ashley-Koch; Michael A Hauser Journal: PLoS One Date: 2012-11-14 Impact factor: 3.240
Authors: Jonathan Janssens; Stéphanie Philtjens; Gernot Kleinberger; Sara Van Mossevelde; Julie van der Zee; Rita Cacace; Sebastiaan Engelborghs; Anne Sieben; Julia Banzhaf-Strathmann; Lubina Dillen; Céline Merlin; Ivy Cuijt; Caroline Robberecht; Bettina Schmid; Patrick Santens; Adrian Ivanoiu; Mathieu Vandenbulcke; Rik Vandenberghe; Patrick Cras; Peter P De Deyn; Jean-Jacques Martin; Stuart Maudsley; Christian Haass; Marc Cruts; Christine Van Broeckhoven Journal: Acta Neuropathol Commun Date: 2015-11-10 Impact factor: 7.801